Literature DB >> 2610512

In vitro susceptibilities of oral bacterial isolates to spiramycin.

E C Chan1, W al-Joburi, S L Cheng, F Delorme.   

Abstract

Four hundred strains of oral bacteria were tested for their susceptibility to spiramycin. Actinobacillus actinomycetemcomitans and most species of Lactobacillus were resistant to the antibiotic. All strains of cariogenic Streptococcus mutans and most strains of bacterial species implicated in adult chronic periodontitis (Bacteroides gingivalis, B. intermedius, and Treponema denticola) were susceptible to spiramycin.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2610512      PMCID： PMC172807          DOI： 10.1128/AAC.33.11.2016

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

Review 1.  Dental caries.

Authors:  R J Gibbons; J van Houte
Journal:  Annu Rev Med       Date:  1975       Impact factor: 13.739

2.  Evaluation of spiramycin as a therapeutic agent for elimination of nasopharyngeal pathogens. Possible use of spiramycin for middle ear infections and for gonococcal and meningococcal nasopharyngeal carriage.

Authors:  C Kamme; G Kahlmeter; A Melander
Journal:  Scand J Infect Dis       Date:  1978

3.  Spiramycin excretion in animals. II. Repeated oral doses in rats.

Authors:  F C Leung; J M Gardner; W S Paor; S L Yankell
Journal:  J Dent Res       Date:  1972 May-Jun       Impact factor: 6.116

4.  Broth dilution minimum inhibitory concentrations: rationale for use of selected antimicrobial concentrations.

Authors:  F G Witebsky; J D Maclowry; S S French
Journal:  J Clin Microbiol       Date:  1979-05       Impact factor: 5.948

5.  Comparison of spiramycin and tetracycline used adjunctively in the treatment of advanced chronic periodontitis.

Authors:  T Chin Quee; W Al-Joburi; C Lautar-Lemay; E C Chan; I Iugovaz; J Bourgouin; F Delorme
Journal:  J Antimicrob Chemother       Date:  1988-07       Impact factor: 5.790

6.  The role of adjunctive Rodogyl therapy in the treatment of advanced periodontal disease. A longitudinal clinical and microbiologic study.

Authors:  T C Quee; E C Chan; C Clark; C Lautar-Lemay; M J Bergeron; J Bourgouin; J Stamm
Journal:  J Periodontol       Date:  1987-09       Impact factor: 6.993

7.  Antibiotic susceptibility of anaerobic bacteria from the human oral cavity.

Authors:  P J Baker; R T Evans; J Slots; R J Genco
Journal:  J Dent Res       Date:  1985-10       Impact factor: 6.116

8.  [Susceptibility of potential periodontopathic bacteria to metronidazole, spiramycin and their combination].

Authors:  C Mouton; L Dextraze; D Mayrand
Journal:  J Biol Buccale       Date:  1984-03

9.  Bacterial specificity in adult periodontitis. A summary of recent work.

Authors:  J Slots
Journal:  J Clin Periodontol       Date:  1986-11       Impact factor: 8.728

10.  Clinical evaluation of spiramycin and erythromycin in control of periodontal disease.

Authors:  W H Mills; G W Thompson; G S Beagrie
Journal:  J Clin Periodontol       Date:  1979-10       Impact factor: 8.728
View more
  3 in total

1.  Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans.

Authors:  R Piccolomini; G Catamo; G Di Bonaventura
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

2.  Screening of aqueous extracts of medicinal herbs for antimicrobial activity against oral bacteria.

Authors:  Nam-Hui Yim; Young Pil Jung; Won-Kyung Cho; Taesoo Kim; Aeyung Kim; Minju Im; Jin Yeul Ma
Journal:  Integr Med Res       Date:  2013-02-09

3.  New Pyrimidinone-Fused 1,4-Naphthoquinone Derivatives Inhibit the Growth of Drug Resistant Oral Bacteria.

Authors:  Kyungmin Kim; Daseul Kim; Hyunjin Lee; Tae Hoon Lee; Ki-Young Kim; Hakwon Kim
Journal:  Biomedicines       Date:  2020-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.